Monash IVF Group Limited (MNIVF)
OTCMKTS
· Delayed Price · Currency is USD
0.5100
-0.2300 (-31.08%)
At close: May 20, 2025
Monash IVF Group Revenue
Monash IVF Group had revenue of 140.39M AUD in the half year ending December 31, 2024, with 35.87% growth. This brings the company's revenue in the last twelve months to 269.79M, up 14.18% year-over-year. In the fiscal year ending June 30, 2024, Monash IVF Group had annual revenue of 255.23M with 19.38% growth.
Revenue (ttm)
269.79M AUD
Revenue Growth
+14.18%
P/S Ratio
1.13
Revenue / Employee
270.61K AUD
Employees
997
Market Cap
188.38M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 255.23M | 41.43M | 19.38% |
Jun 30, 2023 | 213.80M | 21.50M | 11.18% |
Jun 30, 2022 | 192.29M | 8.69M | 4.73% |
Jun 30, 2021 | 183.61M | 38.19M | 26.26% |
Jun 30, 2020 | 145.42M | -6.56M | -4.32% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |